News

New MedTech for Erectile Dysfunction in Men with Benign Prostatic Hyperplasia (BPH) and Chronic Prostatitis Developed by Fine Treatment

OXFORD, UK / ACCESSWIRE / October 13, 2023 / Benign prostate enlargement, known as BPH or BPE, and chronic prostatitis…

9 months ago

BioTools Innovator Names Limula 2023 Winner

Cell Therapy Manufacturing Company Wins $250,000 Grand Prize at the BioTools Innovator Capstone EventLOS ANGELES--(BUSINESS WIRE)--#diagnostics--BioTools Innovator, the first-ever accelerator…

9 months ago

Establishment Labs Announces Two-Year Mia Femtech Clinical Results and the Launch of Zen at 8th World Symposium on Ergonomic Implants

In a 100-patient study of Mia there were no reports of capsular contracture or rupture. The new Zensor™ RFID platform…

9 months ago

Masimo ORi™ Granted De Novo as the First and Only FDA-Cleared Noninvasive and Continuous Parameter to Provide Insight into Hyperoxia Under Supplemental Oxygen

ORi to Be Launched in the U.S. at ANESTHESIOLOGY 2023 This WeekendSAN FRANCISCO--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that ORi™,…

9 months ago

Covalon Presents Innovative Solutions Used in Top Hospitals at the Association for Vascular Access (AVA) Annual Scientific Meeting in Portland, OR

Visit Covalon at booth 715 at the AVA Conference and Exhibit to discover true compassionate vascular access solutionsMISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon…

9 months ago

Rising Diagnosis and Treatment Rates of ADHD in Canadian Adults: Dr. Gurdeep Parhar, MD, Provides Historical Perspective and Current Insights

Attention Deficit Hyperactivity Disorder (ADHD) is Not a Rare Condition as Five Percent of Canadian Adults (1 in 20) Have…

9 months ago

Protagenic Therapeutics Announces Date of Annual Shareholder Meeting

NEW YORK, NY / ACCESSWIRE / October 13, 2023 / Protagenic Therapeutics, Inc. (NASDAQ:PTIX) a biopharmaceutical company focused on developing…

9 months ago

Ensysce Biosciences Releases “Highlights Video” of PAINWeek 2023 Symposium

~ A showcase of PF614 and PF614-MPAR ~SAN DIEGO, CA / ACCESSWIRE / October 13, 2023 / Ensysce Biosciences, Inc.…

9 months ago

Delivra Health Brands to Hold Conference Call to Discuss Annual Financial Results for the Fiscal Year Ending June 30, 2023

Vancouver, British Columbia--(Newsfile Corp. - October 13, 2023) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) (Delivra Health" or…

9 months ago

Outset Medical Reports Preliminary Third Quarter 2023 Financial Results

Conference Call Scheduled for 4:30 p.m. ETSAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), today announced…

9 months ago